Contact

location_on

74 rue des Suisses
92000 Nanterre
France

Gaël Gesbert
Directeur business développement et innovation

About us

CliniSciences is a French company, present in 15 European countries and the United States, with a range of activities:

- Distribution of products for research, production and diagnosis

- Production of reagents and kits for research and diagnostics

- Custom production services (peptides, proteins and antibodies)

- Sourcing organic products of human origin

Our customers are scientists from diagnostic laboratories to the pharmaceutical industry, including biotechs and academic laboratories.

Business offer

Chemical production of peptides and proteins for therapeutic, antigenic, vaccine or diagnostic purposes (R&D and GMP)

Biological production of proteins and antibodies

Supply of flasks for the production of recombinant proteins (bacterial vectors, mammalian cells, insect cells)

Supply of culture media for the production of antibodies and recombinant proteins (bacterial vectors, mammalian cells, insect cells)

Sourcing of human biological products: PBMC, Leukopaks, tissues (R&D and GMP)

Activities

    Categories

    • Service
    • Technology Supplier

    Therapeutic applications

    • Cardiology
    • Genetic Diseases
    • Oncology
    • Nervous Central System
    • Hematology
    • Infectiology
    • Immunology
    • Ophthalmology
    • Inflammation

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Target selection & validation
    • Assay development in in-vitro & in-vivo models
    • Research exploratory companion biomarkers
    • Hit discovery
    • Screening & Identification
    • Therapeutic libraries
    • In silico
    • In-vivo models
    • In-vitro & ex-vivo models
    • Bioinformatics prediction & analysis
    • Immunotherapy lead generation
    • Manufacturability
    • Production quality
    • CMC feasibility
    • Cell activation
    • Avidity testing
    • Cell-based activation (APCs, AAPCs)
    • Bead-base activation
    • Antibody-based activation
    • Ex-vivo activation (cell transfer)
    • In-vivo activation (in human transgenic mouse models)
    • Gene modification / Transduction
    • Retroviral & lentiviral vectors
    • Transposon/transposase
    • mRNA electroporation
    • CRISPR/Cas9
    • Immunotherapy lead optimization
    • Engineering
    • ADC
    • Linkers
    • Payloads
    • Protein scaffolds
    • Fragments
    • Multi-, bispecific
    • Fc-fusion proteins
    • Antibody humanization
    • Proof of concept
    • Pharmacology potency
    • Exploratory toxicology
    • in-vitro & ex-vivo models
    • in-vivo models
    • Preclinical biomarkers
    • Research exploratory Companion biomarkers
    • Human biomarkers
    • Predictive biomarkers
    • Treatment efficacy
    • Population stratification
    • CMC
    • Master Cell Bank
    • Production
    • Cell Line development
    • Clone selection
    • Characterization
    • Storage
    • Analytical development
    • Cell Culture
    • Media composition
    • Bioreactor conditions
    • Gene modification / Transduction
    • Retroviral & lentiviral vectors
    • Cell expansion
    • Stirred tank reactors
    • Bioproduction
    • Batches production type
    • Mammalian
    • Insect
    • Yeast
    • Bacterial
    • GLP compliance
    • GMP compliance
    • Pilot Batches
    • Tests
    • Optimization
    • Scale-Up process
    • Process optimization & validation
    • Volume
    • Preclinical / Tox
    • Low volume (< 200 L)
    • High volume (200 – 2000 L)
    • Fill & Finish
    • Aseptic filling
    • Lyophilization
    • Batch release
    • Storage matter
    • Instruction
    • Logistic
    • Cell cryopreservation
    • Controlled-rated freezer
    • thaw
    • Quality assurance, quality control & analytical process
    • Stability Assessment
    • Physical & chemical profile
    • Shear/shaking
    • Viscosity
    • Photostability
    • pH
    • Freeze/thaw
    • Heat/degradation
    • Aggregation
    • Cell line analytical development
    • Host cell proteins
    • Viral clearance
    • Contaminants detection
    • Clinical trials
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Clinical biomarkers
    • Predictive biomarkers
    • Treatment efficacy
    • Population stratification
    • Risk/benefit profile
    • Surrogate markers
    • Companion biomarkers
    • Treatment efficacy
    Cell Therapy Directory
    • Cell origin
    • Single donor
    • Pool of donors
    • Cell Banking
    • IPs
    • MSC
    • CD34 + HSC cells
    • Tissue acquisition
    • Off the shelf
    • Apheresis
    • Target cell isolation
    • iPS reprogramming
    • Differentiated Cell
    • Production Cell
    • Safety donor-derived therapies
    • Cell modification
    • Direct reprogramming
    • Cell Activation
    • Ex Vivo & In Vivo Strategy
    • Ex Vivo & In Vivo Strategy
    • Bioproduction engineering
    • Purification/Extraction
    • Filtration / microfiltration / ultrafiltration
    • Centrifugation
    • Chromatography
    • Bioproduction modeling
    • Metabolic / Kinetic modeling
    • Control / command
    • Global optimization
    • Economic analyses
    • Artificial Intelligence tools
    • Conditioning
    • Storage
    • Delivery
    • Transport
    • Supply chain logistics
    • Tracking process
    • Monitoring logistics
    Gene and CAR-T cell therapy Directory
    • Gene Cloning
    • Gene augmentation
    • Gene inhibition
    • Killing Gene
    • KI / KO
    • (Gene) engineering
    • CRISPR activation
    • CRISPR interference
    • TRAC gene editing
    • TALEN
    • Gene Delivery System
    • Lentivirus
    • Other Retrovirus
    • Adeno-Associated Virus (AAV)
    • Adenovirus (ADV)
    • Gene Gun
    • Electroporation
    • Lipid chemical methods
    • Protein chemical methods
    • Mixed chemical methods
    • Inorganic methods
    • Binder Generation
    • Mouse immunization
    • Hybridoma
    • Cell procurement
    • Autologous
    • Ex Vivo & In Vivo Strategy
    • Ex Vivo & In Vivo Strategy
    • Bioproduction/CMC/Analytical Quality Assessment, Quality Control
    • Bioproduction
    Prophylactic Vaccines Directory
    • Antigen identification, selection, optimization, and validation
    • Antigen characterization
    • Antigen optimization:
    • Generation of mutants
    • Early purification
    • Early formulation
    • Antigen selection: pathogen sequencing and functional antigens
    • Surface glycoproteins
    • Strongly immunogenic
    • Mutation variability
    • Membrane antigens
    • Outer-membrane proteins (OMP), toxins
    • Internal protein
    • Less immunogenic
    • Conservative sequence
    • Vaccine: antigen format platforms
    • Recombinant protein expression
    • Bacterial
    • Cell
    • Fungi
    • Synthetic Peptides or oligomers
    • Virus-like particles (VLP) and nanoparticle-based carriers
    • Viral vector encoding target antigen
    • Challenge test – Gold Standard
    • In-vitro models
    • CMC
    • GLP compliance
    • for preclinical NCS (non-clinical safety) studies
    • viral safety testing
    • GMP compliance
    • Master Banks (cell and viral as needed)
    • manufacturing
    • Characterization and testing
    • storage
    • shipment
    • Cell Culture / Fermentation
    • media formulation and supply
    • Bioreactor conditions (cell in suspension, adherent cell player)
    • Ability to work in BSL2 conditions
    • Cell expansion
    • Single use technology (SUS)
    • Wave-mixed bioreactors
    • Stirred tank reactors
    • Gene modification / Transduction
    • Molecular biology
    • Expression systems
    • Formulation
    • Formulation
    • Lyophilization
    • Regulatory safety
    • Regulatory safety tests
    • Clinical trials
    • Phase I
    • Phase II (human challenge trials)
    • Phase III (large population pending pathogen prevalence)
    • Bioproduction GMP
    • Vaccine platform type
    • Recombinant protein expression
    • Synthetic Peptides or oligomers
    • Other
    • Fill & finish
    • Lyophilization
    • Vaccine shipment and distribution
    • Storage matter
    • Labelling
    • Packaging for shipping
    • Quality control & analytical process monitoring
    • Stability Assessment
    • Batch release test
    • Chemical, physical, biological testing
Français English